|
Volumn 22, Issue 12, 2012, Pages 4133-4138
|
Evaluation of endo- and exo-aryl-substitutions and central scaffold modifications on diphenyl substituted alkanes as 5-lipoxygenase activating protein inhibitors
|
Author keywords
5 Lipoxygenase activating protein; Antiasthmatic; FLAP inhibitors
|
Indexed keywords
LIPOXYGENASE INHIBITOR;
ANIMAL CELL;
ARTICLE;
CHEMICAL MODIFICATION;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
IC 50;
MAXIMUM PLASMA CONCENTRATION;
MOUSE;
NONHUMAN;
STRUCTURE ACTIVITY RELATION;
5-LIPOXYGENASE-ACTIVATING PROTEIN INHIBITORS;
5-LIPOXYGENASE-ACTIVATING PROTEINS;
ALKANES;
ANIMALS;
ANTI-ALLERGIC AGENTS;
BENZENE DERIVATIVES;
HUMANS;
INHIBITORY CONCENTRATION 50;
INJECTIONS, INTRAVENOUS;
NEUTROPHILS;
RATS;
STEREOISOMERISM;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84861573873
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2012.04.064 Document Type: Article |
Times cited : (21)
|
References (9)
|